Seminal fluid ribavirin level and functional semen parameters in patients with chronic hepatitis C on antiviral combination therapy.

  • Harald Hofer
  • Josef Donnerer
  • Kathrin Sator
  • Katharina Staufer
  • Thomas-Matthias Scherzer
  • Clemens Dejaco
  • Michael Sator
  • Harald Kessler
  • Peter Ferenci

Abstract

Due to the possible teratogenic effect of ribavirin, effective contraception is mandatory during antiviral therapy in patients with chronic hepatitis C (CHC). The aim of this study was to evaluate seminal parameters and ribavirin and HCV-RNA concentrations in seminal fluid and serum prior to and during antiviral treatment.

Bibliografische Daten

OriginalspracheDeutsch
Aufsatznummer6
ISSN0168-8278
StatusVeröffentlicht - 2010
pubmed 20399525